Production of antifungal recombinant peptides in Escherichia coli

Journal of Biotechnology

Volumn 79, Issue 2, 2000, Pages 127-136

  Gavit, Patrick ^a   Better, Marc ^a  

^a XOMA Corporation   (United States)

Author keywords

Antifungal; Aspartyl prolyl cleavage; Bactericidal permeability increasing protein; Escherichia coli; Peptide

Indexed keywords

ANTIFUNGAL AGENT; PEPTIDE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; BIOREACTOR; DILUTION; DRUG ISOLATION; ESCHERICHIA COLI; HYDROLYSIS; NONHUMAN; PH; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; BIOREACTORS; CANDIDA ALBICANS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDE BIOSYNTHESIS; RECOMBINANT FUSION PROTEINS;

ARRHENIUS; BACTERIA (MICROORGANISMS); CANDIDA; ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0034724941     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1656(00)00213-3     Document Type: Article

References (30)

1. Bongers J., Lambros T., Liu W. et al. Enzymatic semisynthesis of a superpotent analog of human growth hormone-releasing factor. J. Med. Chem. 35:1992;3934-3941.
2. Bongers J., Offord R.E., Felix A.M., Campbell R.M., Heimer E.P. Semisynthesis of human growth hormone-releasing factor by trypsin catalyzed coupling of leucine amide to a C-terminal acid precursor. Int. J. Peptide Protein Res. 40:1992;268-273.
3. Callaway J.E., Lai J., Haselbeck B. et al. Modification of the C terminus of cecropin is essential for broad-spectrum antimicrobial activity. Antimicrob. Agents Chemother. 37:1993;1614-1619.
4. Dykes C.W., Bookless A.B., Coomber B.A., Noble S.A., Humber D.C., Hobden A.N. Expression of atrial natriuretic factor as a cleavable fusion protein with chloramphenicol acetyltransferase in Escherichia coli. Eur. J. Biochem. 174:1988;411-416.
5. Forsberg G., Baastrup B., Brobjer M., Lake M., Jornvall H., Hartmanis M. Comparison of two chemical cleavage methods for preparation of a truncated form of recombinant human insulin-like growth factor I from a secreted fusion protein. Biofactors. 2:1989;105-112.
6. Forsberg G., Baastrup B., Rondahl H. et al. An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on Des(1-3) insulin-like growth factor I. J. Protein Chem. 11:1992;201-211.
7. Gazzano-Santoro H., Parent J.B., Grinna L. et al. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect. Immun. 60:1992;4754-4761.
8. Gram H., Ramage P., Memmert K., Gamse R., Kocher H.P. A novel approach for high level production of a recombinant human parathyroid hormone fragment in Escherichia coli. Bio/Technology. 12:1994;1017-1023.
9. Haught C., Davis G.D., Subramanian R., Jackson K.W., Harrison R.G. Recombinant production and purification of novel antisense antimicrobial peptide in Escherichia coli. Biotechnol. Bioeng. 57:1998;55-61.
10. Johnston S., Lee J.H., Ray D.S. High-level expression of M13 gene II protein from an inducible polycistronic messenger RNA. Gene. 34:1985;137-145.
11. Kelley W.S. Therapeutic peptides: the devil is in the details. Bio/Technology. 14:1996;28-31.
12. Kempe T., Kent S., Chow F. et al. Multiple-copy genes: production and modification of monomeric peptides from large multimeric fusion proteins. Gene. 39:1985;239-245.
13. Knott J.A., Sullivan C.A., Weston A. The isolation and characterization of human atrial natriuretic factor produced as a fusion protein in Escherichia coli. Eur. J. Biochem. 174:1988;405-410.
14. Lee J.H., Minn I., Park C., Kim S.C. Acidic peptide-mediated expression of the antimicrobial peptide buforin II as tandem repeats in Escherichia coli. Protein Exp. Purif. 12:1998;53-60.
15. Lei S.P., Lin H.C., Wang S.S., Callaway J., Wilcox G. Characterization of the Erwinia carotovora pelB gene and its product pectate lyase. J. Bacteriol. 169:1987;4379-4383.
16. Lennick M., Haynes J.R., Shen S.-H. High-level expression of α-human atrial natriuretic peptide from multiple joined genes in Escherichia coli. Gene. 61:1987;103-112.
17. 23). J. Biol. Chem. 269:1994;1865-1872.
18. Marcus F. Preferential cleavage at aspartyl-prolyl peptide bonds in dilute acid. Int. J. Pept. Protein Res. 25:1985;542-546.
19. Merkler D.J. C-terminal amidated peptides: production by the in vitro enzymatic amidation of glycine-extended peptides and the importance of the amide to bioactivity. Enzym. Microb. Technol. 16:1994;450-456.
20. Merrifield R.B., Stewart J.M., Jernberg N. Instrument for automated synthesis of peptides. Anal. Chem. 38:1966;1905-1914.
21. Moks T., Abrahmsen L., Oesterlof B. et al. Large scale affinity purification of human insulin-like growth factor I from culture medium of Escherichia coli. Bio/Technology. 5:1987;379-382.
22. Ozkaynak E., Rueger D.C., Drier E.A. et al. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J. 9:1990;2085-2093.
23. Park C., Lee J.H., Hong S.S., Lee H.S., Kim S.C. High-level expression of the angiotensin-converting-enzyme-inhibiting peptide, YG-1, as tandem multimers in Escherichia coli. Appl. Microbiol. Biotechnol. 50:1998;71-76.
24. Piers K.L., Brown M.H., Hancock R.E.W. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene. 134:1993;7-13.
25. Pilon A., Yost P., Chase T.E. et al. Ubiquitin fusion technology: bioprocessing of peptides. Biotechnol. Prog. 13:1997;374-379.
26. Ray M.V., Van Duyne P., Bertelsen A.H. et al. Production of recombinant salmon calcitonin by in vitro amidation of an Escherichia coli produced precursor peptide. Bio/Technology. 11:1993;64-70.
27. Shen S. Multiple joined genes prevent product degradation in Escherichia coli. Proc. Natl. Acad. Sci. 81:1984;4627-4631.
28. Weiss J., Elsbach P., Olsson I., Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J. Biol. Chem. 253:1978;2664-2672.
29. 2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J. Clin. Invest. 90:1992;1122-1130.
30. Wright T.H. Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins. Crit. Rev. Biochem. Mol. Biol. 26:1991;1-52.